Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-28T06:35:08.429Z Has data issue: false hasContentIssue false

Chapter 15 - Sleep Disturbances in Parkinson’s Disease

Published online by Cambridge University Press:  05 March 2022

By
Cristian Falup-Pecurariu ,
Ștefania Diaconu  and
Maria-Lucia Muntean
Edited by
Néstor Gálvez-Jiménez ,
Amos D. Korczyn  and
Ramón Lugo-Sanchez
Néstor Gálvez-Jiménez
Affiliation:
Florida International University
Amos D. Korczyn
Affiliation:
Tel-Aviv University
Ramón Lugo-Sanchez
Affiliation:
Cleveland Clinic
Get access

Summary

Non-motor symptoms (NMS) are important features in Parkinson’s disease (PD). Sleep disturbances have a high prevalence among NMS and affect quality of life of PD patients [1]. In this chapter we will describe the most important features of the main sleep disorders encountered in PD.

Type
Chapter
Information
Non-motor Parkinson's Disease , pp. 167 - 177
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chaudhuri, KR, Healy, DG, Schapira, AH. National Institute for Clinical Excellence. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 2006; 5(3): 235–245.Google Scholar
Maestri, M, Romigi, A, Schirru, A, et al. Excessive daytime sleepiness and fatigue in neurological disorders. Sleep Breath 2019; 24(2): 413–424.Google Scholar
Knie, B, Mitra, MT, Logishetty, K, Chaudhuri, KR. Excessive daytime sleepiness in patients with Parkinson’s disease. CNS Drugs 2011; 25(3): 203–212.CrossRefGoogle ScholarPubMed
Ghorayeb, I, Loundou, A, Auquier, P, et al. A nationwide survey of excessive daytime sleepiness in Parkinson’s disease in France. Mov Disord 2007; 22(11): 1567–1572.CrossRefGoogle ScholarPubMed
Xiang, YQ, Xu, Q, Sun, QY, et al. Clinical features and correlates of excessive daytime sleepiness in Parkinson’s disease. Front Neurol 2019; 10: 121.Google Scholar
Yoo, SW, Kim, JS, Oh, YS, Ryu, DW, Lee, KS. Excessive daytime sleepiness and its impact on quality of life in de novo Parkinson’s disease. Neurol Sci 2019; 40(6): 1151–1156.Google Scholar
Amara, AW, Chahine, LM, Caspell-Garcia, C, et al. Parkinson’s Progression Markers Initiative. Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s disease. J Neurol Neurosurg Psychiatry 2017; 88(8): 653–662.Google Scholar
Marano, M, Gupta, D, Motolese, F, et al. Excessive daytime sleepiness is associated to the development of swallowing impairment in a cohort of early stage drug naïve Parkinson’s disease patients. J Neurol Sci 2019; 410: 116626.Google Scholar
Yousaf, T, Pagano, G, Niccolini, F, Politis, M. Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease. J Neurol Sci 2018; 387: 220–227.Google Scholar
Ashraf-Ganjouei, A, Kheiri, G, Masoudi, M, et al. White matter tract alterations in drug-naïve Parkinson’s disease patients with excessive daytime sleepiness. Front Neurol 2019; 10: 378.Google Scholar
Wilson, H, Pagano, G, Niccolini, F, et al. The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson’s disease. Parkinsonism Relat Disord 2019; 77: 163–169.Google Scholar
Sobreira-Neto, MA, Pena-Pereira, MA, Sobreira, EST, et al. Factors related to excessive sleepiness in patients with Parkinson’s disease. Neurol Res 2019; 41(3): 227–233.CrossRefGoogle ScholarPubMed
Bassetti, CLA, Adamantidis, A, Burdakov, D, et al. Narcolepsy – clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 2019; 15(9): 519–539.Google Scholar
Drouot, X, Moutereau, S, Nguyen, JP, et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 2003; 61(4): 540–543.CrossRefGoogle ScholarPubMed
Overeem, S, van Hilten, JJ, Ripley, B, et al. Normal hypocretin-1 levels in Parkinson’s disease patients with excessive daytime sleepiness. Neurology 2002; 58(3): 498–499.Google Scholar
Thannickal, TC, Lai, YY, Siegel, JM. Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson’s disease. Brain 2008; 131(Pt 1): e87.CrossRefGoogle ScholarPubMed
Hagell, P, Broman, JE. Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson’s disease. J Sleep Res 2007; 16(1): 102–109.Google Scholar
Kurtis, MM, Balestrino, R, Rodriguez-Blazquez, C, Forjaz, MJ, Martinez-Martin, P. A review of scales to evaluate sleep disturbances in movement disorders. Front Neurol 2018; 9: 369.CrossRefGoogle ScholarPubMed
Shpirer, I, Miniovitz, A, Klein, C, et al. Excessive daytime sleepiness in patients with Parkinson’s disease: a polysomnography study. Mov Disord 2006; 21(9): 1432–1438.Google Scholar
Calandrella, A, Albanese, A. Management of sleep disorders in Parkinson’s disease. In: Gálvez-Jiménez NG, Fernandez HH, Espay AJ, Fox SH, (eds.). Parkinson’s Disease: Current and Future Thrapeutics and Clinical Trials. Cambridge University Press; 2016, 151–161.CrossRefGoogle Scholar
Videnovic, A, Klerman, EB, Wang, W, et al. Timed light therapy for sleep and daytime sleepiness associated with Parkinson disease: a randomized clinical trial. JAMA Neurol 2017; 74(4): 411–418.Google Scholar
Lou, JS, Dimitrova, DM, Park, BS, et al. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study. Clin Neuropharmacol 2009; 32(6): 305–310.CrossRefGoogle ScholarPubMed
Büchele, F, Hackius, M, Schreglmann, SR, et al. Sodium oxybate for excessive daytime sleepiness and sleep disturbance in Parkinson disease: a randomized clinical trial. JAMA Neurol 2018; 75(1): 114–118.Google Scholar
Devos, D, Krystkowiak, P, Clement, F, et al. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 2007; 78(5): 470–475.CrossRefGoogle ScholarPubMed
Darien, I. The International Classification of Sleep Disorders, 3rd ed. American Academy of Sleep Medicine; 2014.Google Scholar
Wallace, DM, Wohlgemuth, WK, Trotti, LM, et al. Practical evaluation and management of insomnia in Parkinson’s disease: a review. Mov Disord Clin Pract 2020. DOI: 10.1002/mdc3.12899Google Scholar
Chung, S, Bohnen, NI, Albin, RL, et al. Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities. J Clin Sleep Med 2013; 9(11): 1131–1137.Google Scholar
Zhu, K, van Hilten, JJ, Marinus, J. The course of insomnia in Parkinson’s disease. Parkinsonism Relat Disord 2016; 33: 51–57.Google Scholar
Kay, DB, Tanner, JJ, Bowers, D. Sleep disturbances and depression severity in patients with Parkinson’s disease. Brain Behav 2018; 8(6): e00967.Google Scholar
Sobreira-Neto, MA, Pena-Pereira, MA, Sobreira, EST, et al. High frequency of sleep disorders in Parkinson’s disease and its relationship with quality of life. Eur Neurol 2017; 78(5–6): 330–337.Google Scholar
Loddo, G, Calandra-Buonaura, G, Sambati, L, et al. The treatment of sleep disorders in Parkinson’s disease: from research to clinical practice. Front Neurol 2017; 8: 42.CrossRefGoogle ScholarPubMed
Shafazand, S, Wallace, DM, Arheart, KL, et al. Insomnia, sleep quality, and quality of life in mild to moderate Parkinson’s disease. Ann Am Thorac Soc 2017; 14(3): 412–419.CrossRefGoogle ScholarPubMed
Tholfsen, LK, Larsen, JP, Schulz, J, Tysnes, OB, Gjerstad, MD. Changes in insomnia subtypes in early Parkinson disease. Neurology 2017; 88(4): 352–358.Google Scholar
Yong, MH, Fook-Chong, S, Pavanni, R, Lim, LL, Tan, EK. Case control polysomnographic studies of sleep disorders in Parkinson’s disease. PLoS One 2011; 6(7): e22511.Google Scholar
Maglione, JE, Liu, L, Neikrug, AB, et al. Actigraphy for the assessment of sleep measures in Parkinson’s disease. Sleep 2013; 36(8): 1209–1217.Google Scholar
Lebrun, C, Gély-Nargeot, MC, Rossignol, A, Geny, C, Bayard, S. Efficacy of cognitive behavioral therapy for insomnia comorbid to Parkinson’s disease: a focus on psychological and daytime functioning with a single-case design with multiple baselines. J Clin Psychol 2019. DOI: 10.1002/jclp.22883Google Scholar
Martino, JK, Freelance, CB, Willis, GL. The effect of light exposure on insomnia and nocturnal movement in Parkinson’s disease: an open label, retrospective, longitudinal study. Sleep Med 2018; 44: 24–31.Google Scholar
Dowling, GA, Mastick, J, Colling, E, et al. Melatonin for sleep disturbances in Parkinson’s disease. Sleep Med 2005; 6(5): 459–466.CrossRefGoogle ScholarPubMed
Menza, M, Dobkin, RD, Marin, H, et al. Treatment of insomnia in Parkinson’s disease: a controlled trial of eszopiclone and placebo. Mov Disord 2010; 25(11): 1708–1714.CrossRefGoogle ScholarPubMed
Rios Romenets, S, Creti, L, Fichten, C, et al. Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson’s disease – a randomized study. Parkinsonism Relat Disord 2013; 19: 670–675.Google Scholar
Fei, L, Zhou, D, Ding, ZT. The efficacy and safety of rotigotine transdermal patch for the treatment of sleep disorders in Parkinson’s disease: a meta-analysis. Sleep Med 2019; 61: 19–25.Google Scholar
Allen, RP, Picchietti, DL, Garcia-Borreguero, D, et al. International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance. Sleep Med 2014; 15(8): 860–873.CrossRefGoogle Scholar
Gonzalez-Latapi, P, Malkani, R. Update on restless legs syndrome: from mechanisms to treatment. Curr Neurol Neurosci Rep 2019; 19(8): 54.CrossRefGoogle ScholarPubMed
Yang, X, Liu, B, Shen, H, et al. Prevalence of restless legs syndrome in Parkinson’s disease: a systematic review and meta-analysis of observational studies. Sleep Med 2018; 43: 40–46.Google Scholar
Moccia, M, Erro, R, Picillo, M, et al. A four-year longitudinal study on restless legs syndrome in Parkinson disease. Sleep 2016; 39(2): 405–412.Google Scholar
Munhoz, RP, Constantino, MCL, Silveira-Moriyama, L. The Parkinson’s disease and restless legs syndrome/Willis-Ekbom disorder link: evidence, biases and clinical relevance. Arq Neuropsiquiatr 2019; 77(1): 47–54.CrossRefGoogle ScholarPubMed
Li, K, Liu, B1, Wang, F, et al. Decreased serum ferritin may be associated with increased restless legs syndrome in Parkinson’s disease (PD): a meta-analysis for the diagnosis of RLS in PD patients. Int J Neurosci 2019; 129(10): 995–1003.Google Scholar
Happe, S, Trenkwalder, C. Movement disorders in sleep: Parkinson’s disease and restless legs syndrome. Biomed Tech 2003; 48(3): 62–67.CrossRefGoogle ScholarPubMed
Covassin, N, Neikrug, AB, Liu, L, et al. Clinical correlates of periodic limb movements in sleep in Parkinson’s disease. J Neurol Sci 2012; 316(1–2): 131–136.CrossRefGoogle ScholarPubMed
Alonso-Navarro, H, García-Martín, E, Agúndez, JAG, Jiménez-Jiménez, FJ. Association between restless legs syndrome and other movement disorders. Neurology 2019; 92(20): 948–964.Google Scholar
Fereshtehnejad, SM, Shafieesabet, M, Shahidi, GA, Delbari, A, Lökk, J. Restless legs syndrome in patients with Parkinson’s disease: a comparative study on prevalence, clinical characteristics, quality of life and nutritional status. Acta Neurol Scand 2015; 131(4): 211–218.Google Scholar
Muntean, ML, Sixel-Döring, F, Trenkwalder, C. Serum ferritin levels in Parkinson’s disease patients with and without restless legs syndrome. Mov Disord Clin Pract 2015; 2(3): 249–252.CrossRefGoogle ScholarPubMed
Walters, AS, LeBrocq, C, Dhar, A, et al. International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4(2): 121–132.Google Scholar
Sharon, D, Allen, RP, Martinez-Martin, P, et al. International RLS Study Group. Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale – The sIRLS. Sleep Med 2019; 54: 94–100.CrossRefGoogle Scholar
Kohnen, R, Martinez-Martin, P, Benes, H, et al. Rating of daytime and nighttime symptoms in RLS: validation of the RLS-6 scale of restless legs syndrome/Willis-Ekbom disease. Sleep Med 2016; 20: 116–122.Google Scholar
Kohnen, R, Martinez-Martin, P, Benes, H, et al. Validation of the Kohnen Restless Legs Syndrome-Quality of Life instrument. Sleep Med 2016; 24: 10–17.Google Scholar
De Cock, VC, Bayard, S, Yu, H, et al. Suggested immobilization test for diagnosis of restless legs syndrome in Parkinson’s disease. Mov Disord 2012; 27(6): 743–749.Google Scholar
You, S, Jeon, SM, Do, SY, Cho, YW. Restless legs syndrome in Parkinson’s disease patients: clinical features including motor and nonmotor symptoms. J Clin Neurol 2019; 15(3): 321–327.CrossRefGoogle ScholarPubMed
Puligheddu, M, Figorilli, M, Aricò, D, et al. Time structure of leg movement activity during sleep in untreated Parkinson disease and effects of dopaminergic treatment. Sleep Med 2014; 15: 816–824.Google Scholar
Wanner, V, Garcia Malo, C, Romero, S, Cano-Pumarega, I, García-Borreguero, D. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome. Adv Pharmacol 2019; 84: 187–205.Google Scholar
Ahmed, M, Hays, R, Steven Poceta, J, et al. Effect of gabapentin enacarbil on individual items of the international restless legs study group rating scale and post-sleep questionnaire in adults with moderate-to-severe primary restless legs syndrome: pooled analysis of 3 randomized trials. Clin Ther 2016; 38: 1726–1737.Google Scholar
Silber, MH, Becker, PM, Buchfuhrer, MJ, et al. The appropriate use of opioids in the treatment of refractory restless legs syndrome. Mayo Clin Proc 2018; 93(1): 59–67.Google Scholar
De Cock, VC. Therapies for restless legs in Parkinson’s disease. Curr Treat Options Neurol 2019; 21(11): 56.Google Scholar
Foldvary-Schaefer, NR, Waters, TE. Sleep-Disordered Breathing. Continuum; 2017, 1093–1116.Google Scholar
Béland, SG, Postuma, RB, Latreille, V, et al. Observational study of the relation between Parkinson’s disease and sleep apnea. J Parkinsons Dis 2015; 5(4): 805–811.Google Scholar
Sobreira-Neto, MA, Pena-Pereira, MA, Sobreira, EST, et al. Obstructive sleep apnea and Parkinson’s disease: characteristics and associated factors. Arq Neuropsiquiatr 2019; 77(9): 609–616.Google Scholar
Crosta, F, Desideri, G, Marini, C. Obstructive sleep apnea syndrome in Parkinson’s disease and other parkinsonisms. Funct Neurol 2017; 32(3): 137–141.Google Scholar
Bahia, CMCS, Pereira, JS2, Lopes, AJ. Laryngopharyngeal motor dysfunction and obstructive sleep apnea in Parkinson’s disease. Sleep Breath 2019; 23(2): 543–550.Google Scholar
Meng, L, Benedetti, A, Lafontaine, AL, et al. Obstructive sleep apnea, CPAP therapy and Parkinson’s disease motor function: a longitudinal study. Parkinsonism Relat Disord 2019; 70: 45–50.Google Scholar
Castel, M, Cochen De Cock, V, Léon, H, Dupuy-Bonafé, I. Mandibular advancement device in Parkinson’s disease: a pilot study on efficacy and usability. Sleep Med 2019; 66: 78–81.CrossRefGoogle ScholarPubMed
Boeve, BF, Silber, MH, Saper, CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007; 130(Pt 11): 2770–2788.Google Scholar
De Cock, VC. Recent data on rapid eye movement sleep behavior disorder in patients with Parkinson disease: analysis of behaviors, movements, and periodic limb movements. Sleep Med 2013; 14(8): 749–753.Google Scholar
Boeve, BF. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 2010; 1184: 15–54.Google Scholar
Gagnon, JF, Bédard, MA, Fantini, ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 2002; 59(4): 585–589.Google Scholar
Mollenhauer, B, Trautmann, E, Sixel-Döring, F, et al. DeNoPa Study Group. Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology 2013; 81(14): 1226–1234.Google Scholar
Sixel-Döring, F, Trautmann, E, Mollenhauer, B, Trenkwalder, C. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 2011; 77(11): 1048–1054.Google Scholar
Krenzer, M, Anaclet, C, Vetrivelan, R, et al. Brainstem and spinal cord circuitry regulating REM sleep and muscle atonia. PLoS One 2011; 6(10): e24998.Google Scholar
Lu, J, Sherman, D, Devor, M, Saper, CB. A putative flip-flop switch for control of REM sleep. Nature 2006; 441(7093): 589–594.Google Scholar
Postuma, RB, Iranzo, A, Hu, M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 2019; 142(3): 744–759.Google Scholar
Lapierre, O, Montplaisir, J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 1992; 42(7): 1371–1374.Google Scholar
Frauscher, B, Iranzo, A, Gaig, C, et al. SINBAR (Sleep Innsbruck Barcelona) Group. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep 2012; 35(6): 835–847.Google Scholar
Iranzo, A, Santamaría, J. Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder. Sleep 2005; 28(2): 203–206.CrossRefGoogle ScholarPubMed
Sixel-Döring, F, Schweitzer, M, Mollenhauer, B, Trenkwalder, C. Intraindividual variability of REM sleep behavior disorder in Parkinson’s disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine. J Clin Sleep Med 2011; 7(1): 75–80.Google Scholar
Howell, MJ, Schenck, CH. Rapid eye movement sleep behavior disorder and neurodegenerative disease. JAMA Neurol 2015; 72(6): 707–712.CrossRefGoogle ScholarPubMed
McGrane, IR, Leung, JG, St Louis, EK, Boeve, BF. Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. Sleep Med 2015; 16(1): 19–26.Google Scholar
Falup-Pecurariu, C, Diaconu, Ş. Sleep dysfunction in Parkinson’s disease. Int Rev Neurobiol 2017; 133: 719–742.Google Scholar
Bhidayasiri, R, Trenkwalder, C. Getting a good night sleep? The importance of recognizing and treating nocturnal hypokinesia in Parkinson’s disease. Parkinsonism Relat Disord 2018; 50: 10–18.Google Scholar
Trenkwalder, C, Kohnen, R, Högl, B, et al. Parkinson’s disease sleep scale–validation of the revised version PDSS-2. Mov Disord 2011; 26(4): 644–652.Google Scholar
Marinus, J, Visser, M, van Hilten, JJ, Lammers, GJ, Stiggelbout, AM. Assessment of sleep and sleepiness in Parkinson disease. Sleep 2003; 26(8): 1049–1054.Google Scholar
Buysse, DJ, Reynolds, CF 3rd, Monk, TH, Berman, SR, Kupfer, DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28(2): 193–213.Google Scholar
Bhidayasiri, R, Sringean, J, Thanawattano, C. Sensor-based evaluation and treatment of nocturnal hypokinesia in Parkinson’s disease: an evidence-based review. Parkinsonism Relat Disord 2016; 22(Suppl 1): S127–133.Google Scholar
Fernández-Pajarín, G, Sesar, Á, Ares, B, Castro, A. Evaluating the efficacy of nocturnal continuous subcutaneous apomorphine infusion in sleep disorders in advanced Parkinson’s disease: the APO-NIGHT Study. J Parkinsons Dis 2016; 6(4): 787.Google Scholar
Sharma, VD, Sengupta, S, Chitnis, S, Amara, AW. Deep brain stimulation and sleep-wake disturbances in Parkinson disease: a review. Front Neurol 2018; 9: 697.Google Scholar
Juri, C, Chaná, P, Tapia, J, Kunstmann, C, Parrao, T. Quetiapine for insomnia in Parkinson disease: results from an open-label trial. Clin Neuropharmacol 2005; 28(4): 185–187.CrossRefGoogle ScholarPubMed
Fernández-Pajarín, G, Sesar, Á, Ares, B, Castro, A. Evaluating the efficacy of nocturnal continuous subcutaneous apomorphine infusion in sleep disorders in advanced Parkinson’s disease: the APO-NIGHT Study. J Parkinsons Dis 2016; 6(4): 787–792.Google Scholar
During, EH, Winkelman, JW. Drug treatment of restless legs syndrome in older adults. Drugs Aging 2019; 36(10): 939–946.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×